SMAD2 and breast carcinoma: To our surprise, CM from miR-218-overexpressing breast cancer cells induced SMAD2/3 phosphorylation in MDA-231 cells (Fig. 4a), whereas the same CM treatment to MC3T3 cells suppressed the level of phospho-SMAD2/3 (Fig. 4b).